StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > who brought the sp to 1.00 ?

<< Previous

Bullboard Posts

Next >>

Comment by davewhoon Jan 29, 2021 3:51pm

164 Views

Post# 32422826

RE:RE:who brought the sp to 1.00 ?

All airline passengers arriving from abroad will also be required to take a mandatory COVID-19 test at the airport and wait in a hotel for up to three days at their own expense until the results arrive, Trudeau said.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023